GRIFOLS SA-ADR (GRFS) Fundamental Analysis & Valuation

NASDAQ:GRFS • US3984384087

Current stock price

7.625 USD
-0.25 (-3.11%)
Last:

This GRFS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. GRFS Profitability Analysis

1.1 Basic Checks

  • In the past year GRFS was profitable.
  • GRFS had a positive operating cash flow in the past year.
  • In the past 5 years GRFS has always been profitable.
  • In multiple years GRFS reported negative operating cash flow during the last 5 years.
GRFS Yearly Net Income VS EBIT VS OCF VS FCFGRFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • GRFS has a better Return On Assets (2.04%) than 88.03% of its industry peers.
  • GRFS has a better Return On Equity (7.63%) than 91.31% of its industry peers.
  • GRFS has a Return On Invested Capital of 4.57%. This is amongst the best in the industry. GRFS outperforms 90.54% of its industry peers.
  • GRFS had an Average Return On Invested Capital over the past 3 years of 3.66%. This is significantly below the industry average of 19.54%.
  • The last Return On Invested Capital (4.57%) for GRFS is above the 3 year average (3.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.04%
ROE 7.63%
ROIC 4.57%
ROA(3y)1.02%
ROA(5y)1%
ROE(3y)3.8%
ROE(5y)3.64%
ROIC(3y)3.66%
ROIC(5y)3.12%
GRFS Yearly ROA, ROE, ROICGRFS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • GRFS has a Profit Margin of 5.34%. This is amongst the best in the industry. GRFS outperforms 88.61% of its industry peers.
  • In the last couple of years the Profit Margin of GRFS has declined.
  • With an excellent Operating Margin value of 16.63%, GRFS belongs to the best of the industry, outperforming 93.05% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GRFS has declined.
  • Looking at the Gross Margin, with a value of 38.00%, GRFS is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
  • GRFS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.63%
PM (TTM) 5.34%
GM 38%
OM growth 3Y12.82%
OM growth 5Y-1.86%
PM growth 3Y15.87%
PM growth 5Y-14.34%
GM growth 3Y1.07%
GM growth 5Y-2.09%
GRFS Yearly Profit, Operating, Gross MarginsGRFS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. GRFS Health Analysis

2.1 Basic Checks

  • GRFS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for GRFS remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for GRFS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, GRFS has a worse debt to assets ratio.
GRFS Yearly Shares OutstandingGRFS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
GRFS Yearly Total Debt VS Total AssetsGRFS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • GRFS has an Altman-Z score of 1.29. This is a bad value and indicates that GRFS is not financially healthy and even has some risk of bankruptcy.
  • GRFS's Altman-Z score of 1.29 is fine compared to the rest of the industry. GRFS outperforms 63.51% of its industry peers.
  • GRFS has a debt to FCF ratio of 14.21. This is a negative value and a sign of low solvency as GRFS would need 14.21 years to pay back of all of its debts.
  • GRFS has a Debt to FCF ratio of 14.21. This is amongst the best in the industry. GRFS outperforms 90.15% of its industry peers.
  • GRFS has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.61, GRFS is doing worse than 78.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 14.21
Altman-Z 1.29
ROIC/WACC0.78
WACC5.86%
GRFS Yearly LT Debt VS Equity VS FCFGRFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • GRFS has a Current Ratio of 2.51. This indicates that GRFS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of GRFS (2.51) is worse than 69.88% of its industry peers.
  • GRFS has a Quick Ratio of 2.51. This is a bad value and indicates that GRFS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GRFS's Quick ratio of 0.88 is on the low side compared to the rest of the industry. GRFS is outperformed by 87.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 0.88
GRFS Yearly Current Assets VS Current LiabilitesGRFS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

3

3. GRFS Growth Analysis

3.1 Past

  • GRFS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.76%.
  • GRFS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.12% yearly.
  • The Revenue has been growing slightly by 4.32% in the past year.
  • The Revenue has been growing slightly by 6.30% on average over the past years.
EPS 1Y (TTM)4.76%
EPS 3Y8.55%
EPS 5Y4.12%
EPS Q2Q%41.77%
Revenue 1Y (TTM)4.32%
Revenue growth 3Y7.34%
Revenue growth 5Y6.3%
Sales Q2Q%94.71%

3.2 Future

  • The Earnings Per Share is expected to decrease by -7.18% on average over the next years.
  • Based on estimates for the next years, GRFS will show a small growth in Revenue. The Revenue will grow by 6.97% on average per year.
EPS Next Y-26.58%
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%
EPS Next 5Y-7.18%
Revenue Next Year-3.15%
Revenue Next 2Y5.3%
Revenue Next 3Y7.1%
Revenue Next 5Y6.97%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GRFS Yearly Revenue VS EstimatesGRFS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
GRFS Yearly EPS VS EstimatesGRFS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

7

4. GRFS Valuation Analysis

4.1 Price/Earnings Ratio

  • GRFS is valuated cheaply with a Price/Earnings ratio of 5.91.
  • Compared to the rest of the industry, the Price/Earnings ratio of GRFS indicates a rather cheap valuation: GRFS is cheaper than 97.49% of the companies listed in the same industry.
  • GRFS is valuated cheaply when we compare the Price/Earnings ratio to 25.79, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 12.82, the valuation of GRFS can be described as correct.
  • Based on the Price/Forward Earnings ratio, GRFS is valued cheaply inside the industry as 96.53% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, GRFS is valued a bit cheaper.
Industry RankSector Rank
PE 5.91
Fwd PE 12.82
GRFS Price Earnings VS Forward Price EarningsGRFS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GRFS is valued cheaply inside the industry as 97.30% of the companies are valued more expensively.
  • GRFS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GRFS is cheaper than 98.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.23
EV/EBITDA 7.42
GRFS Per share dataGRFS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The decent profitability rating of GRFS may justify a higher PE ratio.
  • A cheap valuation may be justified as GRFS's earnings are expected to decrease with -24.68% in the coming years.
PEG (NY)N/A
PEG (5Y)1.44
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%

7

5. GRFS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.15%, GRFS is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.27, GRFS pays a better dividend. On top of this GRFS pays more dividend than 99.23% of the companies listed in the same industry.
  • GRFS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 5.15%

5.2 History

  • The dividend of GRFS has a limited annual growth rate of 2.54%.
  • GRFS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.54%
Div Incr Years0
Div Non Decr Years0
GRFS Yearly Dividends per shareGRFS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 31.84% of the earnings are spent on dividend by GRFS. This is a low number and sustainable payout ratio.
DP31.84%
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%
GRFS Yearly Income VS Free CF VS DividendGRFS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M
GRFS Dividend Payout.GRFS Dividend Payout, showing the Payout Ratio.GRFS Dividend Payout.PayoutRetained Earnings

GRFS Fundamentals: All Metrics, Ratios and Statistics

GRIFOLS SA-ADR

NASDAQ:GRFS (3/19/2026, 11:37:29 AM)

7.625

-0.25 (-3.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-27
Earnings (Next)05-11
Inst Owners33%
Inst Owner Change0.5%
Ins Owners6.36%
Ins Owner ChangeN/A
Market Cap5.19B
Revenue(TTM)7.52B
Net Income(TTM)402.00M
Analysts77.14
Price Target12.99 (70.36%)
Short Float %2.51%
Short Ratio11.66
Dividend
Industry RankSector Rank
Dividend Yield 5.15%
Yearly Dividend0.22
Dividend Growth(5Y)2.54%
DP31.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.85%
PT rev (3m)-0.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.3%
EPS NY rev (3m)-1.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 5.91
Fwd PE 12.82
P/S 0.6
P/FCF 7.23
P/OCF 4.31
P/B 0.86
P/tB N/A
EV/EBITDA 7.42
EPS(TTM)1.29
EY16.92%
EPS(NY)0.59
Fwd EY7.8%
FCF(TTM)1.05
FCFY13.83%
OCF(TTM)1.77
OCFY23.2%
SpS12.71
BVpS8.91
TBVpS-7.25
PEG (NY)N/A
PEG (5Y)1.44
Graham Number16.08
Profitability
Industry RankSector Rank
ROA 2.04%
ROE 7.63%
ROCE 7.07%
ROIC 4.57%
ROICexc 4.8%
ROICexgc 11.12%
OM 16.63%
PM (TTM) 5.34%
GM 38%
FCFM 8.29%
ROA(3y)1.02%
ROA(5y)1%
ROE(3y)3.8%
ROE(5y)3.64%
ROIC(3y)3.66%
ROIC(5y)3.12%
ROICexc(3y)3.89%
ROICexc(5y)3.37%
ROICexgc(3y)8.95%
ROICexgc(5y)7.77%
ROCE(3y)5.67%
ROCE(5y)4.83%
ROICexgc growth 3Y30.14%
ROICexgc growth 5Y2.58%
ROICexc growth 3Y26.13%
ROICexc growth 5Y0.31%
OM growth 3Y12.82%
OM growth 5Y-1.86%
PM growth 3Y15.87%
PM growth 5Y-14.34%
GM growth 3Y1.07%
GM growth 5Y-2.09%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 14.21
Debt/EBITDA 4.98
Cap/Depr 94%
Cap/Sales 5.62%
Interest Coverage 2.35
Cash Conversion 61.55%
Profit Quality 155.22%
Current Ratio 2.51
Quick Ratio 0.88
Altman-Z 1.29
F-Score6
WACC5.86%
ROIC/WACC0.78
Cap/Depr(3y)67.96%
Cap/Depr(5y)76.71%
Cap/Sales(3y)2.47%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.76%
EPS 3Y8.55%
EPS 5Y4.12%
EPS Q2Q%41.77%
EPS Next Y-26.58%
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%
EPS Next 5Y-7.18%
Revenue 1Y (TTM)4.32%
Revenue growth 3Y7.34%
Revenue growth 5Y6.3%
Sales Q2Q%94.71%
Revenue Next Year-3.15%
Revenue Next 2Y5.3%
Revenue Next 3Y7.1%
Revenue Next 5Y6.97%
EBIT growth 1Y8.29%
EBIT growth 3Y21.23%
EBIT growth 5Y5.1%
EBIT Next Year43.73%
EBIT Next 3Y20.32%
EBIT Next 5Y17.93%
FCF growth 1Y377.36%
FCF growth 3YN/A
FCF growth 5Y-3.55%
OCF growth 1Y734.85%
OCF growth 3YN/A
OCF growth 5Y-1.17%

GRIFOLS SA-ADR / GRFS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GRIFOLS SA-ADR?

ChartMill assigns a fundamental rating of 5 / 10 to GRFS.


What is the valuation status of GRIFOLS SA-ADR (GRFS) stock?

ChartMill assigns a valuation rating of 7 / 10 to GRIFOLS SA-ADR (GRFS). This can be considered as Undervalued.


What is the profitability of GRFS stock?

GRIFOLS SA-ADR (GRFS) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for GRFS stock?

The Price/Earnings (PE) ratio for GRIFOLS SA-ADR (GRFS) is 5.91 and the Price/Book (PB) ratio is 0.86.


What is the financial health of GRIFOLS SA-ADR (GRFS) stock?

The financial health rating of GRIFOLS SA-ADR (GRFS) is 3 / 10.